Soft Gelatin Capsules Market Size, Share, Growth, and Industry Analysis, By Type (Gelatin Type, Non-animal Type), By Application (Health Supplements, Pharmaceutical, Others), Regional Insights and Forecast From 2026 To 2035

Soft Gelatin Capsules Market Overview

The global soft gelatin capsules market is projected to reach USD 8,013.97 million by 2035, increasing from USD 5,234.94 million in 2026. Market expansion is supported by growing pharmaceutical and nutraceutical demand, rising consumer preference for convenient dosage forms, and increasing adoption of softgel formulations for vitamins, supplements, and medicines. Advancements in encapsulation technologies and improved formulation capabilities are further supporting market development. The market is expected to register a CAGR of 4.8% during the forecast period from 2026 to 2035.

The Soft Gelatin Capsules Market is expanding as pharmaceutical, nutraceutical, and consumer-health manufacturers increasingly select softgels for liquid, semi-solid, and oil-based formulations. Soft gelatin capsules provide accurate dosing, convenient swallowing, effective taste and odor masking, and strong compatibility with lipid-based formulations. The format is particularly relevant for vitamins, minerals, omega fatty acids, botanical ingredients, prescription medicines, and over-the-counter products. Manufacturing capabilities now include conventional gelatin shells, vegetarian alternatives, specialized release systems, enteric technologies, and customized shapes. North America represented approximately 42.25% of the global Soft Gelatin Capsules Market, supported by established pharmaceutical manufacturing, dietary supplement consumption, and mature contract development and manufacturing infrastructure.

The United States remains a major Soft Gelatin Capsules Market because of its extensive pharmaceutical and dietary supplement industries, established contract manufacturing ecosystem, and strong consumer preference for convenient oral dosage forms. Softgels are widely used for vitamins, minerals, omega oils, specialty supplements, prescription products, and over-the-counter medicines. Manufacturers are also investing in plant-based shells, smaller dosage formats, improved fill formulations, and advanced delivery systems. The U.S. accounted for approximately 32.36% of global softgel demand, reflecting its importance as a center for formulation development, commercial manufacturing, private-label production, and consumer-health innovation.

Key Report Takeaways

• By Type: Gelatin Type capsules lead with an estimated 72% market share, while Non-animal Type capsules are projected to be the fastest-growing segment at a CAGR of 6.1%.
• By Application: Health Supplements dominate with approximately 51% market share, supported by rising consumer preference for convenient and easy-to-consume nutritional formulations.
• By Geography: North America holds the largest regional share at approximately 34%, while Asia-Pacific is expected to register the fastest growth at a CAGR of 6.2%, driven by pharmaceutical production and expanding dietary supplement consumption.

Soft Gelatin Capsules Market Latest Trends

A prominent trend in the Soft Gelatin Capsules Market is the development of plant-based and animal-free alternatives designed to address changing consumer preferences. Manufacturers are introducing softgel technologies based on plant-derived polymers and other non-animal materials for customers seeking vegetarian, vegan, kosher, halal, or clean-label formulations. Improvements in shell stability, texture, processing performance, and compatibility with different fills are helping non-animal softgels move beyond niche applications. Plant-based softgels represented approximately 18% of specialty softgel demand, demonstrating the increasing commercial relevance of alternative capsule technologies within pharmaceutical and nutraceutical manufacturing.

Another important trend is the integration of advanced formulation science with softgel manufacturing to address poorly soluble active pharmaceutical ingredients and complex nutraceutical formulations. Lipid-based delivery systems can improve dissolution and absorption characteristics, while specialized capsule designs can support targeted release and sensitive ingredients. Manufacturers are also emphasizing smaller capsules, chewable formats, customized shapes, precision filling, inline printing, and integrated packaging. Pharmaceutical applications represented approximately 35% of global softgel demand, reflecting the importance of drug-delivery innovation alongside traditional supplement applications and creating opportunities for specialized contract development and manufacturing organizations.

Soft Gelatin Capsules Market Dynamics

DRIVER

"Rising demand for convenient oral dosage forms"

Growing demand for convenient oral dosage forms is a primary driver of the Soft Gelatin Capsules Market because consumers and patients often prefer dosage formats that are easy to swallow, accurately dosed, and capable of masking unpleasant tastes or odors. Softgels are particularly effective for oils, lipid-based ingredients, vitamins, botanical extracts, and active pharmaceutical ingredients that may be difficult to formulate as conventional tablets. Pharmaceutical and nutraceutical companies also value the ability to integrate formulation, encapsulation, and packaging through specialized manufacturing partners. Health supplement applications represented approximately 40% of softgel consumption, demonstrating the importance of consumer wellness products to market expansion.

RESTRAINT

"Volatility in gelatin and specialized raw-material costs"

Raw-material costs remain a restraint for the Soft Gelatin Capsules Market because gelatin, plasticizers, colorants, opacifiers, and specialized fill materials directly influence manufacturing economics. Gelatin sourcing can also be affected by animal-origin requirements, regional regulations, food safety standards, and customer preferences regarding bovine, porcine, or fish-derived materials. Alternative shell technologies can reduce dependence on animal gelatin but may require additional formulation expertise and process optimization. Gelatin-based products represented approximately 72% of softgel demand, indicating that conventional raw-material supply remains highly important to the overall industry and continues to influence production planning and pricing strategies.

OPPORTUNITY

"Expansion of bioavailability-enhancing drug delivery"

The increasing number of poorly water-soluble pharmaceutical compounds creates a significant opportunity for the Soft Gelatin Capsules Market because lipid-based softgel formulations can support enhanced solubilization and absorption strategies. Contract development and manufacturing organizations are expanding formulation-development capabilities to combine active ingredients with appropriate oils, surfactants, co-solvents, and self-emulsifying systems. Specialized softgels can also support controlled, delayed, or targeted delivery concepts. Bioavailability-focused formulations represented approximately 22% of pharmaceutical softgel development activity, highlighting the opportunity for manufacturers with formulation science, analytical testing, clinical development, and commercial-scale encapsulation capabilities.

CHALLENGE

"Complex manufacturing and stringent quality requirements"

Manufacturing consistency remains a major challenge because softgel production requires close control of gelatin preparation, fill viscosity, ribbon formation, encapsulation, drying, inspection, and packaging. Variations in moisture, shell thickness, fill compatibility, temperature, or drying conditions can affect capsule appearance, mechanical strength, stability, and dissolution behavior. Pharmaceutical softgels also require strict compliance with quality systems, analytical testing, process validation, and regulatory expectations. Contract manufacturing represented approximately 30% of softgel production demand, increasing the importance of reliable technology transfer, process control, batch reproducibility, documentation, and supply-chain coordination among manufacturers serving multiple pharmaceutical and nutraceutical customers.

Soft Gelatin Capsules Market Segmentation

The Soft Gelatin Capsules Market is segmented by type and application according to shell composition, formulation requirements, end-user preferences, and therapeutic purpose. Gelatin Type includes conventional soft capsules produced with animal-derived gelatin, while Non-animal Type includes plant-based technologies designed for vegetarian, vegan, religious, and clean-label requirements. Application segmentation covers Health Supplements, Pharmaceutical products, and Others such as beauty products, specialty nutrition, animal health, and consumer wellness formulations. Each segment requires different approaches to shell formulation, fill compatibility, stability, packaging, labeling, and regulatory compliance. Pharmaceutical products represented approximately 35% of market demand, emphasizing the importance of technically advanced softgel solutions.

By Type

Based on Type, the Global market can be categorized into, Gelatin Type, Non-animal Type.

• Gelatin Type: Gelatin Type remains the established foundation of the Soft Gelatin Capsules Market because gelatin provides favorable film-forming properties, elasticity, transparency, mechanical strength, and compatibility with rotary-die encapsulation. Manufacturers can adjust shell characteristics through gelatin selection, plasticizer concentration, moisture management, colorants, and processing conditions. Gelatin softgels are extensively used for pharmaceutical products, vitamins, minerals, omega oils, botanical extracts, and over-the-counter formulations. Established production infrastructure and regulatory familiarity support broad adoption across major manufacturing regions. Conventional gelatin capsules represented approximately 72% of softgel demand, maintaining their position as the dominant product type despite increasing competition from plant-based capsule technologies.

• Non-animal Type: Non-animal Type softgels are gaining strategic importance as consumers and pharmaceutical companies increasingly seek vegetarian, vegan, halal, kosher, and clean-label dosage formats. Plant-based shell systems can be formulated using polysaccharides and other materials designed to provide soft texture, flexibility, stability, and appropriate encapsulation performance. Recent technology improvements are addressing historical limitations related to processing conditions, shell integrity, cross-linking, storage stability, and fill compatibility. Non-animal softgels represented approximately 18% of specialty softgel demand, creating an attractive opportunity for manufacturers capable of delivering scalable plant-based technologies without compromising product appearance, performance, shelf stability, or regulatory compliance.

By Application

• Health Supplements: Health Supplements represent a major application for the Soft Gelatin Capsules Market because softgels are particularly suitable for vitamins, minerals, omega oils, herbal extracts, antioxidants, beauty supplements, and specialty nutrition products. Consumers associate softgels with convenient dosing and smooth swallowing, while manufacturers benefit from the ability to encapsulate liquids and oils that are difficult to compress into tablets. Private-label supplement companies and branded wellness manufacturers increasingly use contract softgel producers for formulation development and commercial production. Health Supplements represented approximately 40% of softgel consumption, supported by preventive health awareness, wellness spending, sports nutrition, healthy aging products, and personalized supplementation.

• Pharmaceutical: Pharmaceutical applications require greater emphasis on formulation development, content uniformity, stability, dissolution, bioavailability, and regulatory compliance. Soft gelatin capsules are used for prescription and over-the-counter products containing lipid-soluble active ingredients, poorly soluble compounds, oils, suspensions, and specialized formulations. Contract development and manufacturing organizations provide formulation screening, analytical testing, clinical supply, scale-up, encapsulation, packaging, and commercial production. Pharmaceutical softgels can also support improved patient acceptance because their smooth shell and flexible format may facilitate swallowing. Pharmaceutical products represented approximately 35% of the Soft Gelatin Capsules Market, creating opportunities for advanced drug-delivery technologies and specialized manufacturing services.

• Others: The Others application category includes beauty supplements, animal health products, specialty consumer healthcare, cosmetics-related ingestible products, and functional nutrition. Softgels are useful in these applications because they can encapsulate oils, botanical extracts, vitamins, antioxidants, and other ingredients requiring protection from light, oxygen, taste, or odor. Beauty-from-within products are particularly compatible with softgel formats because ingredients associated with skin, hair, and nail health can be delivered in visually differentiated capsules. Other applications represented approximately 25% of softgel demand, demonstrating the diversity of markets beyond conventional pharmaceutical and dietary supplement products and supporting continued product-form innovation.

Soft Gelatin Capsules Market Regional Outlook

• North America

North America is the dominant Soft Gelatin Capsules Market region because the United States combines a large pharmaceutical sector with mature dietary supplement consumption and extensive contract development and manufacturing capabilities. Softgels are widely used for vitamins, omega fatty acids, specialty supplements, prescription medicines, over-the-counter products, and wellness formulations. Manufacturers in the region are also investing in plant-based shells, advanced formulation systems, smaller capsules, chewable formats, and specialized drug-delivery technologies. North America represented approximately 42.25% of the global market, reflecting the region’s strong combination of consumer demand, pharmaceutical development, established manufacturing networks, and sophisticated distribution infrastructure.

The United States also benefits from a highly developed private-label supplement industry, allowing contract manufacturers to produce differentiated softgel products for numerous brands. Demand for customized formulations encourages manufacturers to provide end-to-end services covering formulation development, sourcing, encapsulation, analytical testing, packaging, and regulatory support. Large manufacturing sites provide substantial production capacity, while specialized facilities handle high-potency and technically challenging formulations. Dietary supplement applications represented approximately 40% of North American softgel consumption, demonstrating how wellness products complement pharmaceutical demand and create a diversified customer base for softgel manufacturers and contract development organizations.

• Europe

Europe represents a significant Soft Gelatin Capsules Market because of its established pharmaceutical manufacturing base, advanced nutraceutical industry, strong regulatory environment, and growing demand for specialized dosage forms. European manufacturers increasingly focus on clean-label formulations, plant-based shells, traceable ingredients, and sustainability-oriented manufacturing practices. Softgels are widely used for vitamins, nutritional oils, specialty medicines, and consumer healthcare products. The region also hosts major contract manufacturers with integrated formulation, encapsulation, packaging, analytical, and supply-chain services. Europe represented approximately 24% of global softgel demand, supported by pharmaceutical innovation, mature nutraceutical markets, and strong customer demand for technically differentiated capsule formats.

European companies are also developing technologies designed to improve softgel manufacturing efficiency and address consumer preferences for animal-free products. Plant-based capsule systems are gaining attention among supplement brands seeking vegetarian or vegan claims, while specialized pharmaceutical softgels are being developed for challenging active ingredients. Regulatory compliance and product traceability remain central competitive factors because manufacturers must satisfy stringent quality expectations across multiple markets. Non-animal softgels represented approximately 18% of specialty European softgel demand, indicating a growing opportunity for manufacturers that can combine plant-based formulations with reliable production performance and appropriate regulatory documentation.

• Asia-Pacific

Asia-Pacific is an important growth region for the Soft Gelatin Capsules Market because of expanding pharmaceutical production, increasing healthcare expenditure, rising consumer awareness of preventive health, and strong nutraceutical manufacturing activity. China, Japan, India, South Korea, and Southeast Asian economies provide opportunities across pharmaceutical, dietary supplement, beauty, and functional nutrition applications. Local manufacturers are expanding production capacity while international companies are developing regional supply chains to serve pharmaceutical and consumer-health customers. Asia-Pacific represented approximately 22% of global softgel demand, reflecting its substantial manufacturing base and growing domestic consumption of health-oriented dosage forms.

China and India are particularly important because both countries have large pharmaceutical and nutraceutical manufacturing ecosystems, while Japan has a mature consumer health market with strong demand for functional foods and supplements. Regional manufacturers increasingly compete through cost efficiency, formulation flexibility, export capabilities, and integrated packaging services. Pharmaceutical contract manufacturing is also becoming more prominent as global companies seek diversified production networks. Pharmaceutical applications represented approximately 33% of Asia-Pacific softgel demand, demonstrating the importance of drug manufacturing alongside dietary supplements and other consumer-health products in regional market development.

• Middle East & Africa

Middle East & Africa is a developing Soft Gelatin Capsules Market supported by pharmaceutical localization, healthcare infrastructure investment, nutritional supplementation, and growing consumer awareness of wellness products. Gulf countries are important markets for premium pharmaceutical and nutraceutical products, while African countries offer opportunities as healthcare access, domestic pharmaceutical production, and distribution networks improve. Softgel manufacturers can address regional demand through localized production, contract manufacturing, distribution partnerships, and formulations aligned with halal requirements. Middle East & Africa represented approximately 7% of global softgel demand, leaving considerable room for suppliers with appropriate regulatory, manufacturing, and regional distribution capabilities.

Demand in the region is supported by vitamins, minerals, omega oils, specialty supplements, and pharmaceutical formulations, with product selection increasingly influenced by quality, safety, religious compliance, and ease of administration. Manufacturers offering halal-compatible gelatin sources and non-animal softgel technologies can address diverse customer requirements. Regional pharmaceutical localization programs may also encourage investment in domestic encapsulation and packaging capabilities, reducing dependence on imported finished products. Nutraceutical applications represented approximately 38% of regional softgel consumption, highlighting the role of wellness products in expanding the addressable market alongside prescription and over-the-counter medicines.

Key Industry Players

The Soft Gelatin Capsules Market has a relatively concentrated competitive structure, with large contract development and manufacturing organizations holding strong positions through extensive manufacturing networks, formulation expertise, regulatory capabilities, and established pharmaceutical relationships. Catalent, Aenova, Procaps, Patheon, CAPTEK, Strides Pharma Science, and Sirio Pharma compete alongside specialized softgel manufacturers and regional suppliers. The top ten competitors collectively represented approximately 29.82% of the market, indicating meaningful concentration while leaving substantial opportunities for regional and niche manufacturers with differentiated technologies.

Competitive strategies increasingly center on advanced formulation technologies, plant-based shells, bioavailability enhancement, digital manufacturing, customized dosage forms, sustainability, and integrated development services. Companies are expanding their ability to support customers from early formulation through clinical development, scale-up, commercial encapsulation, packaging, and lifecycle management. Innovation also includes specialized release profiles, smaller capsules, chewable softgels, precision filling, and improved shell technologies. Contract development and manufacturing services represented approximately 30% of market activity, reinforcing the importance of integrated technical support and long-term pharmaceutical customer relationships.

Emerging competitive opportunities are developing in vegan softgels, cannabinoid formulations, specialty nutrition, complex lipid-based drug delivery, high-potency products, pediatric dosage forms, and customized consumer-health applications. Strategic collaborations between softgel manufacturers and pharmaceutical or consumer-health companies can accelerate formulation development and market entry. Regional expansion is also important as manufacturers seek local production and shorter supply chains. Specialty softgel technologies represented approximately 20% of new development activity, creating opportunities for companies that combine formulation science, flexible manufacturing, regulatory expertise, and differentiated capsule technology.

List of Top Soft Gelatin Capsules Companies

• Catalent
• Aenova
• Nature’s Bounty
• Procaps
• Patheon (Thermo Fisher Scientific)
• Aland
• EuroCaps
• Captek
• Strides Pharma Science
• Lonza (Capsugel)
• Soft Gel Technologies
• Amway
• Sirio Pharma
• Baihe Biotech
• Ziguang Group
• Shineway
• Donghai Pharm
• By-Health
• Yuwang Group
• Guangdong Yichao

Top Two Companies with Highest Market Share

• Catalent: approximately 4.70% market share, supported by extensive softgel development and manufacturing capabilities, integrated formulation services, specialized delivery technologies, global production infrastructure, and strong pharmaceutical and consumer-health customer relationships.
• Aenova: approximately 4.51% market share, supported by large-scale softgel production, integrated development and packaging services, pharmaceutical and nutraceutical expertise, international manufacturing capabilities, and expanding plant-based softgel technologies.

Investment Analysis and Opportunities

Investment opportunities in the Soft Gelatin Capsules Market are concentrated in production capacity, advanced formulation development, plant-based shell technology, high-potency manufacturing, specialty drug delivery, and integrated contract manufacturing. Companies that can offer development through commercial supply are positioned to capture greater customer value because pharmaceutical and nutraceutical clients increasingly prefer simplified outsourcing models. Investment in automated encapsulation, inspection, drying, packaging, and digital quality systems can improve production efficiency and consistency. Contract manufacturing represented approximately 30% of market activity, making scalable CDMO infrastructure an attractive area for capital deployment and strategic expansion.

Another investment opportunity lies in non-animal softgel technologies and formulations designed for sensitive active ingredients. Consumer preference for vegan and clean-label products is encouraging manufacturers to develop stable plant-based shell systems, while pharmaceutical companies require specialized solutions for poorly soluble compounds and advanced oral delivery. Investors can also target regional capacity expansions in Asia-Pacific, Latin America, and emerging healthcare markets where pharmaceutical and nutraceutical manufacturing is developing rapidly. Plant-based products represented approximately 18% of specialty softgel demand, creating an opportunity for manufacturers that can scale alternative-shell technologies while maintaining quality and cost competitiveness.

New Product Development

New Product Development in the Soft Gelatin Capsules Market is increasingly focused on plant-based softgels, chewable softgels, smaller dosage forms, customized shapes, controlled-release systems, and formulations that improve bioavailability. Advanced capsule technologies can help manufacturers address poorly soluble active ingredients and sensitive compounds while maintaining consumer-friendly dosage characteristics. Companies are also developing specialized softgels for beauty nutrition, sports supplements, omega oils, cannabinoids, probiotics, and complex pharmaceutical formulations. Plant-based softgel products represented approximately 18% of specialty development demand, demonstrating the commercial importance of alternative shells and differentiated dosage forms.

Innovation is also advancing through formulation screening, automated manufacturing, precision filling, improved drying systems, advanced analytical testing, and digitally supported product development. Integrated development centers enable manufacturers to evaluate active ingredients, excipients, shell compositions, fill viscosity, dissolution, stability, and packaging compatibility before commercial scale-up. Specialized capsule designs are increasingly being used to address drug-delivery challenges rather than serving solely as passive containers. Bioavailability-enhancing products represented approximately 22% of pharmaceutical softgel development activity, reinforcing the shift toward technically differentiated capsules capable of supporting more complex formulations and targeted delivery objectives.

Five Recent Developments

• November 2023: The agreement strengthened access to pharmaceutical and consumer-health channels and supported broader commercialization of softgel products, reinforcing Procaps’ approximately 3.20% market share.
• June 2024: The technology strengthened Lonza’s specialized capsule innovation position and supported its estimated 2.25% market share.
• September 2024: The initiative expanded collaborative development capabilities and strengthened Lonza’s position in specialized capsule services, supporting its estimated 2.25% market share.
• December 2024: The initiative was designed to support targeted drug delivery, capsule customization, and formulation development through the Innovaform Accelerator, reinforcing Lonza’s estimated 2.25% market share in the broader capsule industry.
• June 2024: By strengthening technical communication around advanced softgel formulation, Aenova supported customer development programs and reinforced its approximately 4.51% market share in the Soft Gelatin Capsules Market.

Report Coverage of Soft Gelatin Capsules Market

The Soft Gelatin Capsules Market report covers product segmentation by Gelatin Type and Non-animal Type, together with application analysis across Health Supplements, Pharmaceutical, and Others. The assessment examines shell formulation, gelatin sourcing, plant-based alternatives, fill technologies, lipid-based delivery systems, encapsulation processes, drying, inspection, packaging, stability, quality control, and regulatory requirements. Regional analysis includes North America, Europe, Asia-Pacific, and Middle East & Africa, with attention to pharmaceutical manufacturing, nutraceutical consumption, consumer wellness preferences, contract manufacturing infrastructure, and emerging dosage-form technologies.

Competitive analysis includes Catalent, Aenova, Nature’s Bounty, Procaps, Patheon, Aland, EuroCaps, Captek, Strides Pharma Science, Lonza, Soft Gel Technologies, Amway, Sirio Pharma, Baihe Biotech, Ziguang Group, Shineway, Donghai Pharm, By-Health, Yuwang Group, and Guangdong Yichao. The report also evaluates investment opportunities involving plant-based softgels, bioavailability enhancement, specialty pharmaceutical formulations, advanced manufacturing, digital quality systems, and regional capacity expansion. Pharmaceutical applications represented approximately 35% of global softgel demand, highlighting the importance of drug-delivery innovation, contract manufacturing, formulation development, and technically advanced capsule platforms across the market.